ORAL COMBINATION THERAPY FOR TREATING HCV INFECTION IN SPECIFIC PATIENT SUB-POPULATION

• 收藏
• 分享

专利权人:

Federico MENSA

发明人:

Federico MENSA

申请号：

US13827125

公开号：

US20130261050A1

申请日:

2013.03.14

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) Compound (2), or a pharmaceutically acceptable salt thereof, as herein described, and optionally (c) ribavirin, and methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient having compensated liver disease.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/